Rockwell Medical, Inc. (RMTI)
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic
$7.52
+4.01%
Mkt Cap $35.57M
Analyst Ratings
No recent rating data.
Price Target (4 analysts)
$2.00
Range $2.00 – $2.00
Implied Upside
-73.4%
Consensus $2.00 vs current $7.52